Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy

Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study

(2019) André Hennigs et al.   ANNALS OF SURGICAL ONCOLOGY

Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases

(2019) Shabaz Majid et al.   BMC CANCER

Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort

(2019) Fabian Riedel et al.   BREAST CANCER RESEARCH AND TREATMENT

The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study

(2018) Ingrid G.M. Poodt et al.   EJSO

Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer

(2018) Monica Morrow et al.   JAMA Oncology

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

(2018) Viviana Galimberti et al.   LANCET ONCOLOGY

Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade

(2018) F. Riedel et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?

(2018) André Hennigs et al.   BREAST CANCER RESEARCH AND TREATMENT

The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer

(2018) Ingrid G.M. Poodt et al.   EJSO

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

(2018) Achim Wöckel et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Upper limb lymphedema in breast cancer patients in the era of Z0011, sentinel lymph node biopsy and breast conservation

(2017) N. R. Bhatt et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Axillary Nodal Management Following Neoadjuvant Chemotherapy

(2017) Melissa Pilewskie et al.   JAMA Oncology

Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015

(2017) Ingrid G. M. Poodt et al.   ANNALS OF SURGERY

Extending ACOSOG Z0011 to Encompass Mastectomy: What Happens Without RT?

(2016) Hiram S. Cody   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift

(2016) Aoife Maguire et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Healthcare Costs Reduced After Incorporating the Results of the American College of Surgeons Oncology Group Z0011 Trial into Clinical Practice

(2016) Michelle M. Fillion et al.   Breast Journal

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

(2015) L. M. van Roozendaal et al.   BMC CANCER

POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases

(2015) A. Goyal et al.   CLINICAL ONCOLOGY

Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer

(2015) Katharine Yao et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Regional Nodal Irradiation in Early-Stage Breast Cancer

(2015) Timothy J. Whelan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is Axillary Lymph Node Dissection Necessary After Sentinel Lymph Node Biopsy in Patients with Mastectomy and Pathological N1 Breast Cancer?

(2014) Yun Fu et al.   ANNALS OF SURGICAL ONCOLOGY

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare Analysis

(2013) Holly Caretta-Weyer et al.   ANNALS OF SURGICAL ONCOLOGY

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

(2013) Viviana Galimberti et al.   LANCET ONCOLOGY

The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?

(2012) U. Güth et al.   EJSO

Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population

(2012) Min Yi et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

To Cut Is to Cure: Can We Really Apply Z11 in Practice?

(2011) Monica Morrow et al.   ANNALS OF SURGICAL ONCOLOGY

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

(2010) Volker Moebus et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY